HIV News and Research

RSS

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Many countries in resource-limited settings have high HIV, malaria, tuberculosis, hepatitis, and/or sexually transmitted infection (STI) burdens.

30 Nov 2020

Oxford University podcast's third season to take listeners on a journey through historical pandemics

The University of Oxford's CASE Gold Award winning podcast, Futuremakers, will return for its third season at the end of October.

30 Nov 2020

HIV-related health services in Thailand during COVID-19 pandemic

Thailand's key population-led health services (KPLHS) are a hallmark of the success of the country's HIV response.

30 Nov 2020

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

University of California San Diego Collaborative Clinical Trials Unit has been selected by the National Institutes of Health to lead and administer an international seven-year, $28-million grant for science-driven clinical trials that deliver innovative, efficient results needed to turn the corner on the HIV/AIDS pandemic.

30 Nov 2020

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

The nonprofit International Partnership for Microbicides is pleased to announce the World Health Organization's prequalification of the dapivirine ring, a monthly vaginal ring to reduce women's HIV risk.

30 Nov 2020

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

In a preprint paper published on the medRxiv server, a team of researchers from various institutions in South Africa, the UK, and Europe discuss how they determined the impact of HIV on the COVID-19 immune response in KwaZulu-Natal, South Africa, which is an area with very high HIV prevalence.

26 Nov 2020

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

A shorter genome comprising only a part of the SARS-CoV-2's RNA genome competes with the normal virus for growth and can potentially prevent viral replication.

26 Nov 2020

New therapy for flu may prove effective against many other pathogenic virus infections

A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.

24 Nov 2020

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Thirteen African countries and an international network of research institutions have joined forces to launch the largest COVID-19 clinical trial in mild-to-moderate outpatients in Africa.

24 Nov 2020

New therapy developed for flu infections may also prove effective against HIV, COVID-19

24 Nov 2020

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

In the COVID-19 pandemic, 57 million people have already been infected worldwide. In the search for vaccines and therapies, a precise understanding of the virus, its mutations, and transmission mechanisms are crucial.

24 Nov 2020

Chemists discover effective inhibitors to block SARS-CoV-2

Some viruses can get inside cells via a mechanism that involves sulfur organic molecules. Chemists at UNIGE have discovered effective inhibitors and blocked the uptake of SARS-CoV-2.

20 Nov 2020

Scientists develop a new vaccine approach for HIV

Unlike so many other deadly viruses, HIV still lacks a vaccine. The virus--which continues to infect millions around the world--has proven especially tricky to prevent with conventional antibodies, in part because it evolves so rapidly in the body.

20 Nov 2020

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Texas Biomedical Research Institute in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.

19 Nov 2020

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.

19 Nov 2020

KHN’s ‘What the Health?’: What would Dr. Fauci do?

Since the mid-1980s, whenever there's been a public health crisis, America — and six U.S. presidents — have turned to Dr. Anthony Fauci.

19 Nov 2020

Triple RNA sequencing dissects gene expression of virus and fungi in infection processes

Organ and stem cell transplants are proven and frequently used methods in everyday modern clinical practice. However, even when performed regularly in specialized centers, some patients still experience a number of serious complications afterward.

19 Nov 2020

"Escape mutations" could help SARS-CoV-2 evade immune attack

Researchers in the United States have identified mutations within severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – that can reduce antibody binding to the virus, potentially mediating its escape from immune attack.

18 Nov 2020

UC researcher receives $443,000 NIH grant to study antiviral drugs

University of Cincinnati pharmaceutical sciences researcher Bingfang Yan, DVM, has received a $443,000 grant from the National Institutes of Health to study how common medicines against viral infections are genetically impacted for therapeutic effectiveness and safety through metabolic conversions in the body.

18 Nov 2020

Conservation of tropical peatlands could reduce the likelihood of new zoonotic diseases

Conservation of tropical peatlands could reduce the impacts of the COVID-19 pandemic and the likelihood of new diseases jumping from animals to humans, researchers say.

17 Nov 2020

HIV News and Research

HIV and TB laboratory systems used to scale up COVID-19 testing in Africa

Oxford University podcast's third season to take listeners on a journey through historical pandemics

HIV-related health services in Thailand during COVID-19 pandemic

UC San Diego chosen to lead an international $28-million grant for HIV/AIDS clinical trials

IPM announces WHO's prequalification of dapivirine ring to reduce women’s HIV risk

HIV alters SARS-CoV-2 immune response without affecting COVID-19 symptoms or outcomes

Researchers develop synthetic defective SARS-CoV-2 genome that inhibits viral replication

New therapy for flu may prove effective against many other pathogenic virus infections

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

New therapy developed for flu infections may also prove effective against HIV, COVID-19

Research provides key information on transmission, development of mutations in SARS-CoV-2 virus

Chemists discover effective inhibitors to block SARS-CoV-2

Scientists develop a new vaccine approach for HIV

Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19

Carrageenan-based composite nasal spray may help prevent SARS-CoV-2 infection

KHN’s ‘What the Health?’: What would Dr. Fauci do?

Triple RNA sequencing dissects gene expression of virus and fungi in infection processes

"Escape mutations" could help SARS-CoV-2 evade immune attack

UC researcher receives $443,000 NIH grant to study antiviral drugs

Conservation of tropical peatlands could reduce the likelihood of new zoonotic diseases

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News